insights_auto
Why is GANX down 4.82%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.00
arrow_downward
-4.82%(-0.051) 1D
US$1.00
arrow_upward
+0.06% (+0.00060)bedtimeAfter hours
Closed: ኖቬም 20, 4:00:02 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.02
High
US$1.10
Low
US$0.97
Mkt. cap
44.50 ሚ
Avg. vol.
690.72 ሺ
Volume
586.26 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.02
High
US$1.10
Low
US$0.97
Mkt. cap
44.50 ሚ
Avg. vol.
690.72 ሺ
Volume
586.26 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
AP News
·
ከ1 ቀን በፊት
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
ከ5 ሰዓቶች በፊት
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Beinsure
·
ከ19 ሰዓቶች በፊት
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
WSJ
·
ከ2 ቀናት በፊት
Dow, S&P 500 Poised to Close at a Correction
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com